An ETV6-NTRK3 fusion has been reported in many types of solid cancers, including secretory breast carcinoma, carcinoma of salivary glands and gastrointestinal system, and acute myelocytic leukemia (AML) (9). This evidence concerns the gene NTRK3 and acute myeloid leukemia.